Analysts Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $513.74

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus recommendation of “Moderate Buy” from the nineteen brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $513.74.

ISRG has been the topic of a number of research reports. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th.

Intuitive Surgical Stock Down 1.9 %

NASDAQ:ISRG opened at $527.61 on Wednesday. Intuitive Surgical has a twelve month low of $295.02 and a twelve month high of $544.38. The company has a fifty day moving average of $498.17 and a 200-day moving average of $456.22. The firm has a market capitalization of $187.92 billion, a P/E ratio of 85.96, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in Intuitive Surgical in the 1st quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.